Related Experiment Video
Updated: Jun 16, 2026
09:57
Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Nanopediatrics: enabling personalized medicine for children
1Departments of Pediatrics and Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA. emccabe@mednet.ucla.edu
Pediatric Research
|February 2, 2010
Summary
This review introduces nanomedicine and nanobiology, focusing on their impact on children's health through nanopediatrics. It highlights advancements in nanodiagnostics, nanotherapeutics, and theranostics for personalized pediatric medicine.
Area of Science:
- Nanobiology and nanomedicine
- Nanotechnology's impact on pediatric health
Background:
- Nanotechnology offers transformative potential in healthcare.
- A dedicated NanoPediatrics Program was established at UCLA to explore these applications.
Purpose of the Study:
- To define nanobiology and nanomedicine within the context of pediatrics.
- To explore the societal and individual implications of nanodisciplines.
- To introduce the concept and rationale for nanopediatrics.
Main Methods:
- Review of current research in nanodiagnostics and nanotherapeutics.
- Discussion of "theranostics"—combined diagnostic and therapeutic nanodevices.
- Case examples from the UCLA NanoPediatrics Program and collaborators.
Main Results:
- Nanodiagnostics and nanotherapeutics show promise for early disease detection and targeted treatment in children.
- Theranostic nanodevices offer integrated approaches for pediatric care.
- The development of nanopediatrics is crucial for advancing personalized medicine.
Conclusions:
- Nanopediatrics represents a critical emerging field for improving children's health.
- Personalized medicine for children can be significantly enhanced through nanotechnology.
- The integration of research, diagnosis, and treatment via nanomedicine is key.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...